{"id":"https://openalex.org/W2964586572","doi":"https://doi.org/10.2500/aap.2019.40.4236","title":"Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study","display_name":"Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study","publication_year":2019,"publication_date":"2019-07-25","ids":{"openalex":"https://openalex.org/W2964586572","doi":"https://doi.org/10.2500/aap.2019.40.4236","mag":"2964586572","pmid":"https://pubmed.ncbi.nlm.nih.gov/31345280"},"language":"en","primary_location":{"id":"doi:10.2500/aap.2019.40.4236","doi":"https://doi.org/10.2500/aap.2019.40.4236","is_oa":false,"landing_page_url":"https://doi.org/10.2500/aap.2019.40.4236","pdf_url":null,"source":{"id":"https://openalex.org/S49250914","display_name":"Allergy and Asthma Proceedings","issn_l":"1088-5412","issn":["1088-5412","1539-6304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320401","host_organization_name":"OceanSide Publications, Inc","host_organization_lineage":["https://openalex.org/P4310320401"],"host_organization_lineage_names":["OceanSide Publications, Inc"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and Asthma Proceedings","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044142108","display_name":"Abhishek Kavati","orcid":"https://orcid.org/0000-0001-8890-1134","observed_orcids":["https://orcid.org/0000-0001-8890-1134"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhishek Kavati","raw_affiliation_strings":["From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025682958","display_name":"Maryia Zhdanava","orcid":"https://orcid.org/0000-0002-7995-2578","observed_orcids":["https://orcid.org/0000-0002-7995-2578"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maryia Zhdanava","raw_affiliation_strings":["Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006031044","display_name":"Benjamin D Ortiz","orcid":"https://orcid.org/0000-0001-6950-5582","observed_orcids":["https://orcid.org/0000-0001-6950-5582"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Ortiz","raw_affiliation_strings":["From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080451932","display_name":"Jason Lecocq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason LeCocq","raw_affiliation_strings":["From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024657457","display_name":"Bradd Schiffman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradd Schiffman","raw_affiliation_strings":["Allergy Partners P.A., Asheville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Partners P.A., Asheville, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090831117","display_name":"Dominic Pilon","orcid":"https://orcid.org/0000-0002-6093-7167","observed_orcids":["https://orcid.org/0000-0002-6093-7167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominic Pilon","raw_affiliation_strings":["Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083056835","display_name":"Hoi Ching Cheung","orcid":"https://orcid.org/0000-0001-7651-4903","observed_orcids":["https://orcid.org/0000-0001-7651-4903","https://orcid.org/0000-0001-5133-8421","https://orcid.org/0009-0009-0418-8761"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hoi Ching Cheung","raw_affiliation_strings":["Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105457474","display_name":"Patrick Lef\u00e8bvre","orcid":"https://orcid.org/0000-0002-2216-5442","observed_orcids":["https://orcid.org/0000-0002-2216-5442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Lefebvre","raw_affiliation_strings":["Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110414017","display_name":"Brian D. Stone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian D. Stone","raw_affiliation_strings":["Allergy Partners of San Diego, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Partners of San Diego, San Diego, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.651,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.89663846,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"40","issue":"5","first_page":"321","last_page":"328"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":1.0},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.8489999771118164},{"id":"https://openalex.org/keywords/anti-ige-therapy","display_name":"anti-IgE therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/urticaria-control","display_name":"urticaria control","score":0.8510000109672546},{"id":"https://openalex.org/keywords/symptom-improvement","display_name":"symptom improvement","score":0.5429999828338623},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.981821596622467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9739558696746826},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.7220640778541565},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.6315850019454956},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.5939674377441406},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5518813133239746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4777076244354248},{"id":"https://openalex.org/C3017745231","wikidata":"https://www.wikidata.org/wiki/Q187440","display_name":"Chronic urticaria","level":2,"score":0.4632941484451294},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.44255462288856506},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.41075652837753296},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34354346990585327},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32570022344589233},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.15011033415794373},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.07925191521644592},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057286","descriptor_name":"Electronic Health Records","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2500/aap.2019.40.4236","doi":"https://doi.org/10.2500/aap.2019.40.4236","is_oa":false,"landing_page_url":"https://doi.org/10.2500/aap.2019.40.4236","pdf_url":null,"source":{"id":"https://openalex.org/S49250914","display_name":"Allergy and Asthma Proceedings","issn_l":"1088-5412","issn":["1088-5412","1539-6304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320401","host_organization_name":"OceanSide Publications, Inc","host_organization_lineage":["https://openalex.org/P4310320401"],"host_organization_lineage_names":["OceanSide Publications, Inc"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and Asthma Proceedings","raw_type":"journal-article"},{"id":"pmid:31345280","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31345280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and asthma proceedings","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2912477156","https://openalex.org/W2911276331","https://openalex.org/W4293230167","https://openalex.org/W2766055111","https://openalex.org/W2767568586","https://openalex.org/W2789682096","https://openalex.org/W2996178852","https://openalex.org/W2763131663","https://openalex.org/W2605435176","https://openalex.org/W3149131680"],"abstract_inverted_index":{"This":[0],"real-world":[1],"study":[2],"showed":[3],"that":[4],"the":[5],"patients":[6],"who":[7],"received":[8],"a":[9,16],"mean":[10,17],"of":[11,18],"15":[12],"omalizumab":[13,30],"administrations":[14],"over":[15],"14.2":[19],"months":[20,28],"experienced,":[21],"starting":[22],"at":[23],"6":[24],"and":[25,32,38],"through":[26],"24":[27],"after":[29],"initiation":[31],"beyond,":[33],"improved":[34],"CIU":[35],"control,":[36],"course,":[37],"symptoms.":[39]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-08-13T00:00:00"}